Cargando…

Initiation of human regular U-500 insulin use is associated with improved glycemic control: a real-world US cohort study

AIM: Describe the characteristics of patients initiating human regular U-500 insulin (U-500R) and their subsequent glycemic control in a real-world setting. METHODS: US Humedica electronic health record system data (July 2007–September 2011) were used to identify patients with diabetes aged ≥18 year...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eby, Elizabeth L, Curtis, Bradley H, Gelwicks, Steven C, Hood, Robert C, Idris, Iskandar, Peters, Anne L, Bergenstal, Richard M, Jackson, Jeffrey A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Epidemiology/Health Services Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419461/ https://www.ncbi.nlm.nih.gov/pubmed/25969741 http://dx.doi.org/10.1136/bmjdrc-2014-000074

Ejemplares similares

Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study
por: Gordon, Jason, et al.
Publicado: (2018)

Delayed Response to U-500 Regular Insulin
por: Davidson, Mayer B.
Publicado: (2018)

Obesity and Undiagnosed Diabetes in the U.S.
por: Wee, Christina C., et al.
Publicado: (2008)

The Dynamics of Diabetes Among Birth Cohorts in the U.S.
por: Fishman, Ezra I., et al.
Publicado: (2014)

Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects
por: de la Peña, Amparo, et al.
Publicado: (2011)

MON-152 Less Is More: Human Regular U-500 Insulin
por: Lugo Lopez, Zahira, et al.
Publicado: (2019)

COVID-19 susceptibility and severity risks in a cross-sectional survey of over 500 000 US adults
por: Knight, Spencer C, et al.
Publicado: (2022)

Ambulatory Treatment of Type 2 Diabetes in the U.S., 1997–2012
por: Turner, Lydia W., et al.
Publicado: (2014)

Metformin Use in Prediabetes Among U.S. Adults, 2005–2012
por: Tseng, Eva, et al.
Publicado: (2017)

Prevalence of Diabetes in U.S. Youth in 2009: The SEARCH for Diabetes in Youth Study
por: Pettitt, David J., et al.
Publicado: (2014)

Trends in Health Care Expenditure in U.S. Adults With Diabetes: 2002–2011
por: Ozieh, Mukoso N., et al.
Publicado: (2015)

Full Accounting of Diabetes and Pre-Diabetes in the U.S. Population in 1988–1994 and 2005–2006
por: Cowie, Catherine C., et al.
Publicado: (2009)

Trends in Emergency Department Visits and Inpatient Admissions for Hyperglycemic Crises in Adults With Diabetes in the U.S., 2006–2015
por: Benoit, Stephen R., et al.
Publicado: (2020)

Herpes Zoster Incidence and Burden in Adults With Type 2 Diabetes in the U.S.: A Retrospective Database Analysis
por: Poirrier, Jean-Etienne, et al.
Publicado: (2022)

Association of Brominated Flame Retardants With Diabetes and Metabolic Syndrome in the U.S. Population, 2003–2004
por: Lim, Ji-Sun, et al.
Publicado: (2008)

Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes
por: Fang, Michael, et al.
Publicado: (2021)

Racial Disparity of Eye Examinations Among the U.S. Working-Age Population With Diabetes: 2002–2009
por: Shi, Qian, et al.
Publicado: (2014)

Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes
por: McCoy, Rozalina G, et al.
Publicado: (2020)

Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate, Vascular Disease, and Mortality in Persons With Diabetes in the U.S.
por: Tsai, Ching-Wei, et al.
Publicado: (2014)

Diabetes Care Disparities in Long-standing Type 1 Diabetes in Canada and the U.S.: A Cross-sectional Comparison
por: Weisman, Alanna, et al.
Publicado: (2018)

Insulin Edema With Use of U-500 Regular Insulin in a Hybrid Closed-Loop Insulin Pump
por: Vasigh, Mostafa, et al.
Publicado: (2020)

Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial
por: Kabul, Samaneh, et al.
Publicado: (2016)

Association of C-Reactive Protein With Reduced Forced Vital Capacity in a Nonsmoking U.S. Population With Metabolic Syndrome and Diabetes
por: Lee, Hwa Mu, et al.
Publicado: (2008)

Trends in Diabetes, High Cholesterol, and Hypertension in Chronic Kidney Disease Among U.S. Adults: 1988–1994 to 1999–2004
por: Fox, Caroline S., et al.
Publicado: (2008)

Understanding the High Prevalence of Diabetes in U.S. South Asians Compared With Four Racial/Ethnic Groups: The MASALA and MESA Studies
por: Kanaya, Alka M., et al.
Publicado: (2014)

Comparing Type 2 Diabetes, Prediabetes, and Their Associated Risk Factors in Asian Indians in India and in the U.S.: The CARRS and MASALA Studies
por: Gujral, Unjali P., et al.
Publicado: (2015)

Mitigating Case Mix Factors by Choice of Glycemic Control Performance Measure Threshold
por: Bainbridge, Kathleen E., et al.
Publicado: (2008)

Metabolic Syndrome, C-Reactive Protein, and Mortality in U.S. Blacks and Whites: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study
por: Suzuki, Takeki, et al.
Publicado: (2014)

Gut Microbiota Metabolites of Dietary Lignans and Risk of Type 2 Diabetes: A Prospective Investigation in Two Cohorts of U.S. Women
por: Sun, Qi, et al.
Publicado: (2014)

Life Years Lost and Lifetime Health Care Expenditures Associated With Diabetes in the U.S., National Health Interview Survey, 1997–2000
por: Leung, Man-Yee Mallory, et al.
Publicado: (2015)

Evaluating the Effect of U-500 Insulin Therapy on Glycemic Control in Veterans With Type 2 Diabetes
por: Granata, Joseph A., et al.
Publicado: (2015)

Association Between Parental History of Type 2 Diabetes and Glycemic Control in Urban African Americans
por: Gong, Lucy, et al.
Publicado: (2008)

Provider beliefs about diabetes treatment have little impact on glycemic control of their patients with diabetes
por: LeBlanc, Erin S, et al.
Publicado: (2015)

Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 U.S. Health Care Organizations
por: Stempniewicz, Nikita, et al.
Publicado: (2021)

Identifying sustainable lifestyle strategies for maintaining good glycemic control: a validation of qualitative findings
por: Weller, Susan C, et al.
Publicado: (2021)

In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens from 69 U.S. Medical Centers (2015): Potency Analysis by U.S. Census Divisions
por: Pfaller, Michael A., et al.
Publicado: (2017)

Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database
por: Alfego, David, et al.
Publicado: (2021)

Diabetes, Glycemic Control, and Risk of Hospitalization With Pneumonia: A population-based case-control study
por: Kornum, Jette B., et al.
Publicado: (2008)

Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas
por: Dawed, Adem Y., et al.
Publicado: (2021)

Development and Implementation of a U-500 Regular Insulin Program in a Federally Qualified Health Center
por: Shaw, Kathy F., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m5so8e4hsc1ssbfk96g74e3v32